High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency.
about
Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococciStructural features and kinetic characterization of alanine racemase fromStaphylococcus aureus(Mu50)Comparative study of the effects of pyridoxine, rifampin, and renal function on hematological adverse events induced by linezolidPopulation pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients.Correlation between serum linezolid concentration and the development of thrombocytopenia.Thrombocytopenia in the intensive care unit.Probable linezolid-induced thrombocytopenia in a patient with vancomycin-resistant enterococci.A reduced linezolid dosage maintains favorable efficacy with minimal hematologic toxicity in a methicillin-resistant Staphylococcus aureus-infected patient with renal insufficiency.High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literature.Efficacy of linezolid on gram-positive bacterial infection in elderly patients and the risk factors associated with thrombocytopenia.Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients.Risk factors for linezolid-associated thrombocytopenia in adult patients.Platelet profile in patients with acute bacterial skin and skin structure infections receiving tedizolid or linezolid: findings from the Phase 3 ESTABLISH clinical trials.The association between risk factors and time of onset for thrombocytopenia in Japanese patients receiving linezolid therapy: a retrospective analysis.Linezolid-Associated Thrombocytopenia in Children With Renal Impairment.Safety profiles of old and new antimicrobials for the treatment of MRSA infections.Mechanism Underlying Linezolid-induced Thrombocytopenia in a Chronic Kidney Failure Mouse Model.Safety and efficacy of commonly used antimicrobial agents in the treatment of enterococcal infections: a review.Update on the safety of linezolid.Effective treatment of post-spinal fusion methicillin-resistant Staphylococcus aureus vertebral osteomyelitis with linezolid in a renal-transplant patient.Clinical update on linezolid in the treatment of Gram-positive bacterial infections.Risk factors for a low linezolid trough plasma concentration in acute infections.Reply to "Breakthrough bacteremia by linezolid-susceptible Enterococcus faecalis under linezolid treatment in a severe polytrauma patient".Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index.Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic reviewLinezolid: a promising option in the treatment of Gram-positives.Pharmacokinetic-pharmacodynamic modeling of the in vitro activities of oxazolidinone antimicrobial agents against methicillin-resistant Staphylococcus aureus.Population pharmacokinetic analysis of linezolid in low body weight patients with renal dysfunction.Safety, tolerability and pharmacokinetics of 21 day multiple oral administration of a new oxazolidinone antibiotic, LCB01-0371, in healthy male subjects.Is it time to revise linezolid doses in peritoneal dialysis patients? A case series.
P2860
Q26853465-C0EBEACE-CD39-4FBD-964D-88AA468AE7B0Q27676379-DE7489B8-98BB-4A6B-8307-C1DA89A7B84DQ33375091-61CDF2A8-F34A-44DE-95BE-0DFE44F0BB6CQ33394332-6EFBDCAC-5FB6-4B82-8B4D-19BC31799E1FQ33397069-58342856-641C-4A89-93AA-BAD1A2232DFFQ33399094-4E4C9E2B-4DA1-4A16-995F-BACD75F9B2D5Q33400991-E56E4038-D571-4297-84EC-B49FFF91895CQ33403406-1D8091FA-DB47-4928-8BFF-1169A4270473Q33407349-0BB79A68-9715-49E7-B213-F0B2F1B2CD89Q33410244-8C038392-01DF-4FBD-A1AE-9BA0CEA3DF33Q33412202-94858711-56BA-4469-BD95-980D474D1384Q33413274-48038D0E-24FA-4889-A92C-77481D7E05FFQ33417036-AB055ED0-5796-4785-9B2E-35CE5F172704Q33417790-2C144C6E-8DB2-4B00-B425-7613BF239D63Q33420826-99ED44A5-8ACD-4FBA-921A-B75F9A16169FQ33426216-AD040F5D-6F13-4935-A1D6-539F068AEFC3Q33429168-FE23D272-FADE-4D5C-A57E-5E680B322EB8Q33440964-A7D804CA-9DBC-4B5A-BCC3-C53EC17AA9A5Q34503844-36E76C60-A6D6-42B1-8AC0-D8626ADF9628Q34987632-3D9F0B35-5EB1-463E-B2F7-D78E477FF4CEQ35851305-E3D9E693-122E-4942-B10F-1116AF5F0919Q36083208-A49FE3EB-137A-4B1C-AF89-73163416C425Q36757691-DD952BD2-1AB0-4988-9648-DB31C2D9E1A1Q37335675-DA322FBC-4C5B-4B92-BEBE-51E702AB1426Q37821604-938650AE-C76E-477B-ACC3-2FAC92681B40Q38929509-27D8799F-6CBC-4980-BA6D-DF1DA74EC21EQ39013332-22C15EF7-2210-4402-92A6-65D9CB37BA9BQ39044932-C55B9F98-A7D5-466F-A1DA-371E1ED71C67Q42687502-3CE99BE4-47BE-4E8A-8EA7-D476F4473717Q47218572-69124876-FA73-464D-BDEB-EE90C5C82F2CQ50082653-5F209944-F861-45B7-A438-399491A38E12Q53440848-265A7E0A-AC74-48DE-BCC8-817115412FE8
P2860
High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
High frequency of linezolid-as ...... ents with renal insufficiency.
@ast
High frequency of linezolid-as ...... ents with renal insufficiency.
@en
type
label
High frequency of linezolid-as ...... ents with renal insufficiency.
@ast
High frequency of linezolid-as ...... ents with renal insufficiency.
@en
prefLabel
High frequency of linezolid-as ...... ents with renal insufficiency.
@ast
High frequency of linezolid-as ...... ents with renal insufficiency.
@en
P50
P1476
High frequency of linezolid-as ...... ents with renal insufficiency.
@en
P2093
Chen-Yi Wu
Yi-Luwn Ho
P304
P356
10.1016/J.IJANTIMICAG.2006.04.017
P577
2006-08-28T00:00:00Z